Cargando…

Torsade de Pointes Due to QT Prolongation after Pulmonary Vein Isolation for Persistent Atrial Fibrillation

We herein report a 60-year-old woman with long-standing persistent atrial fibrillation (AF) who developed QT prolongation and torsade de pointes (TdP) after pulmonary vein isolation (PVI). When electrical cardioversion was performed three months before PVI, prominent QT prolongation was not observed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chikata, Akio, Kato, Takeshi, Usuda, Kazuo, Fujita, Shuhei, Otowa, Kan-Ichi, Maruyama, Michiro, Hayashi, Kenshi, Takamura, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313932/ https://www.ncbi.nlm.nih.gov/pubmed/33518578 http://dx.doi.org/10.2169/internalmedicine.6627-20

Ejemplares similares

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

Successful revascularization with percutaneous coronary intervention using a combination of the subintimal transcatheter withdrawal technique and coronary artery fenestration for spontaneous coronary artery dissection
por: Matsuura, Shintaro, et al.
Publicado: (2021)

Refractory Monomorphic Ventricular Tachycardia Induced by Anamorelin
por: Sakagami, Hiroaki, et al.
Publicado: (2022)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2017)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Recurrent takotsubo with prolonged QT and torsade de pointes and left ventricular thrombus
por: Ahmed, Alaa Eldin K., et al.
Publicado: (2017)

Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man
por: Guess, Joel, et al.
Publicado: (2018)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation
por: Ösken, Altuğ, et al.
Publicado: (2016)

The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department
por: Cole, Jon B., et al.
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation
por: Shimizu, Masato, et al.
Publicado: (2016)

QT Prolongation Complicated with Torsades de Pointes in Prosthetic Mitral Valve Endocarditis: A Case Report
por: Tounsi, A., et al.
Publicado: (2012)

QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H(1) receptor antagonists
por: Acosta-Materán, Carlos, et al.
Publicado: (2016)

Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug
por: Schlit, Anne‐Françoise, et al.
Publicado: (2017)

A Case of Hypoglycemiainduced QT Prolongation Leading to Torsade de Pointes and a Review of Pathophysiological Mechanisms
por: Hannoodi, Faris, et al.
Publicado: (2017)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Comment on “The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department”
por: DiSalvo, Philip C., et al.
Publicado: (2021)

His Bundle Pacing in Amiodarone-Induced Complete Heart Block, QT Prolongation, and Torsade de Pointes
por: Tan, Vern Hsen, et al.
Publicado: (2020)

Diphenhydramine-Induced Torsade De Pointes With Pharmacological Cardioversion in a Patient With Methadone-Induced QT Prolongation
por: Hoffman, Jamie P, et al.
Publicado: (2022)

QT Dispersion and Drug-Induced Torsade de Pointes
por: Friedman, Ari, et al.
Publicado: (2021)

QT interval prolongation and torsade de pointes induced by left ventricular pacing rescued by His bundle pacing
por: Lador, Adi, et al.
Publicado: (2020)

Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone
por: Tziatzios, Georgios D, et al.
Publicado: (2020)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
por: Nordkin, Irina, et al.
Publicado: (2020)

Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
por: El-Sherif, Nabil, et al.
Publicado: (2019)

Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System
por: Teng, Chengwen, et al.
Publicado: (2019)

Long QT Syndrome and Torsade de Pointes Associated with Takotsubo Cardiomyopathy
por: Ahn, Ji Hun, et al.
Publicado: (2011)

Long QT syndrome and torsade de pointes after anthracycline chemotherapy
por: Colombo, N, et al.
Publicado: (2009)

Shock From Twisting Peaks: A Rare Case of Recurrent Torsades de Pointes Secondary to Leuprolide-Induced Prolonged QT
por: Abbasi, Danish, et al.
Publicado: (2020)

3542 Torsade de pointes/QT prolongation risks with antibiotics: A contemporary analysis of the FDA Adverse Event Reporting System
por: Teng, Chengwen, et al.
Publicado: (2019)

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study
por: Hafermann, Matthew J, et al.
Publicado: (2011)

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
por: Jankelson, Lior, et al.
Publicado: (2020)

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2010)

Drug-Induced Long-QT and Torsades de Pointes in Elderly Polymedicated Patients
por: García-Fuertes, Daniel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s6ba8lvrc22f61s3lmeadp1sls